Page last updated: 2024-11-05

dodecylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dodecylamine is a long-chain aliphatic amine that finds applications in various industries. It is typically synthesized through the reaction of dodecyl alcohol with ammonia in the presence of a catalyst. This compound exhibits surfactant properties, acting as an emulsifier, wetting agent, and corrosion inhibitor. Dodecylamine is utilized in the production of detergents, cosmetics, and pharmaceuticals. It is studied for its potential applications in the fields of drug delivery, gene therapy, and nanotechnology. Its amphiphilic nature allows it to interact with both hydrophobic and hydrophilic environments, making it valuable in various scientific and industrial processes.'

dodecylamine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID13583
CHEMBL ID109904
CHEBI ID193593
SCHEMBL ID25484
MeSH IDM0045066

Synonyms (74)

Synonym
bdbm50147554
EN300-40533
AKOS015843225
124-22-1
alamine 4
amine bb
farmin 20d
1-aminododecane
n-laurylamine
lauramine
armeen 12d
1-dodecylamine
laurylamine
nissan amine bb
einecs 204-690-6
hsdb 2645
monododecylamine
n-dodecylamine
kemamine p690
brn 1633576
laurinamine
lauryl amine
ai3-15083
1-dodecanamine
dodecylamine
dodecan-1-amine
dodecylamine, 98%
dodecylamine, >=99%
NCGC00164141-01
D0980
CHEMBL109904 ,
CHEBI:193593
NCGC00164141-02
dodecanamine
NCGC00256405-01
tox21_302940
cas-124-22-1
dtxcid901984
dtxsid3021984 ,
NCGC00259449-01
tox21_201900
dodecyl-amine
68155-27-1
ec 268-953-7
einecs 268-953-7
4-04-00-00794 (beilstein handbook reference)
ec 204-690-6
ywy9od6a2k ,
unii-ywy9od6a2k
FT-0627730
dodecylamine [hsdb]
lauramine [inci]
STL268899
SCHEMBL25484
n-dodecyl-amine
1-dodecyl amine
amine-12
c12h25-nh2
n-dodecyl amine
dodecyl amine
amine 12
Q-201036
armeen 12
mfcd00008154
F0001-0378
dodecylamine, puriss., >=99.5% (gc)
Q21091987
armeen 12d; farmin 20d; han 12
DTXSID801022411 ,
STR02320
dodecane-1-amine
dodecylamin
1-aminododecane dodecylamine laurylamine
CS-0013582

Research Excerpts

Overview

Dodecylamine appears to be a universal sporicide with a novel mechanism of action. This or some comparable molecule could be useful in wide area spore decontamination.

ExcerptReferenceRelevance
"Dodecylamine appears to be a universal sporicide with a novel mechanism of action, and this or some comparable molecule could be useful in wide area spore decontamination."( Dodecylamine rapidly kills of spores of multiple Firmicute species: properties of the killed spores and the mechanism of the killing.
DeMarco, AM; Granados, MR; Korza, G; Mok, WWK; Setlow, P, 2021
)
2.79

Toxicity

ExcerptReferenceRelevance
" From all the experiments, it was concluded that all the three PdO nanosuspension are toxic in nature to both the cells and to genome, although, bishexadecyltrimethyl ammonium palladium tetrachloride (PdCTAC) Ns was found to be the most cytotoxic and genotoxic."( Toxicity assessment of palladium oxide nanoparticles derived from metallosurfactants using multi assay techniques in Allium sativum.
Dogra, V; Kaur, G; Kumar, R; Kumar, S, 2020
)
0.56

Compound-Compound Interactions

ExcerptReferenceRelevance
" Accordingly, a new method of PT/MS-LLLME combined with LVSS-CE/UV was developed for the simultaneous speciation of inorganic and organic mercury species."( Phase transfer membrane supported liquid-liquid-liquid microextraction combined with large volume sample injection capillary electrophoresis-ultraviolet detection for the speciation of inorganic and organic mercury.
Hu, B; Li, P; Zhang, X, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
primary aliphatic amine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (17)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency27.70230.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency48.33820.000714.592883.7951AID1259369; AID1259392
progesterone receptorHomo sapiens (human)Potency69.14800.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency35.21360.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency50.82440.000817.505159.3239AID1159527; AID1159531
pregnane X nuclear receptorHomo sapiens (human)Potency59.20520.005428.02631,258.9301AID1346982
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency58.66670.001019.414170.9645AID743140
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency65.58290.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency30.88730.001628.015177.1139AID1224843
activating transcription factor 6Homo sapiens (human)Potency22.04910.143427.612159.8106AID1159516
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency49.36190.057821.109761.2679AID1159528
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency69.14800.000323.4451159.6830AID743065
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency41.51790.000627.21521,122.0200AID743202; AID743219
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency65.58290.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency65.58290.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Epoxide hydrolase 1 Homo sapiens (human)IC50 (µMol)12.90000.04002.98007.0000AID1691497
Dynamin-1Homo sapiens (human)IC50 (µMol)12.90003.15004.17335.0000AID63727
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (35)

Processvia Protein(s)Taxonomy
xenobiotic metabolic processEpoxide hydrolase 1 Homo sapiens (human)
response to toxic substanceEpoxide hydrolase 1 Homo sapiens (human)
response to organic cyclic compoundEpoxide hydrolase 1 Homo sapiens (human)
arachidonic acid metabolic processEpoxide hydrolase 1 Homo sapiens (human)
catabolic processEpoxide hydrolase 1 Homo sapiens (human)
epoxide metabolic processEpoxide hydrolase 1 Homo sapiens (human)
endocytosisDynamin-1Homo sapiens (human)
receptor-mediated endocytosisDynamin-1Homo sapiens (human)
endosome organizationDynamin-1Homo sapiens (human)
modulation of chemical synaptic transmissionDynamin-1Homo sapiens (human)
protein homooligomerizationDynamin-1Homo sapiens (human)
protein homotetramerizationDynamin-1Homo sapiens (human)
regulation of vesicle sizeDynamin-1Homo sapiens (human)
clathrin coat assembly involved in endocytosisDynamin-1Homo sapiens (human)
vesicle scissionDynamin-1Homo sapiens (human)
receptor internalizationDynamin-1Homo sapiens (human)
synaptic vesicle budding from presynaptic endocytic zone membraneDynamin-1Homo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (20)

Processvia Protein(s)Taxonomy
epoxide hydrolase activityEpoxide hydrolase 1 Homo sapiens (human)
protein bindingEpoxide hydrolase 1 Homo sapiens (human)
oxysterol bindingEpoxide hydrolase 1 Homo sapiens (human)
cis-stilbene-oxide hydrolase activityEpoxide hydrolase 1 Homo sapiens (human)
RNA bindingDynamin-1Homo sapiens (human)
GTPase activityDynamin-1Homo sapiens (human)
protein bindingDynamin-1Homo sapiens (human)
GTP bindingDynamin-1Homo sapiens (human)
phosphatidylinositol-4,5-bisphosphate bindingDynamin-1Homo sapiens (human)
phosphatidylinositol-3,4,5-trisphosphate bindingDynamin-1Homo sapiens (human)
GDP bindingDynamin-1Homo sapiens (human)
protein kinase bindingDynamin-1Homo sapiens (human)
identical protein bindingDynamin-1Homo sapiens (human)
protein homodimerization activityDynamin-1Homo sapiens (human)
microtubule bindingDynamin-1Homo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (25)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneEpoxide hydrolase 1 Homo sapiens (human)
photoreceptor inner segmentDynamin-1Homo sapiens (human)
plasma membraneDynamin-1Homo sapiens (human)
clathrin-coated pitDynamin-1Homo sapiens (human)
endocytic vesicleDynamin-1Homo sapiens (human)
chromaffin granuleDynamin-1Homo sapiens (human)
cell projectionDynamin-1Homo sapiens (human)
extracellular exosomeDynamin-1Homo sapiens (human)
photoreceptor ribbon synapseDynamin-1Homo sapiens (human)
presynapseDynamin-1Homo sapiens (human)
presynaptic endocytic zone membraneDynamin-1Homo sapiens (human)
glutamatergic synapseDynamin-1Homo sapiens (human)
membrane coatDynamin-1Homo sapiens (human)
plasma membraneDynamin-1Homo sapiens (human)
synapseDynamin-1Homo sapiens (human)
microtubuleDynamin-1Homo sapiens (human)
cytoplasmDynamin-1Homo sapiens (human)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID1691498Inhibition of human mEH at 100 uM using CMNGC as substrate preincubated for 5 mins followed by substrate addition and measured at 30 secs interval for 10 mins by fluorescence assay relative to control2020European journal of medicinal chemistry, May-01, Volume: 193Development of potent inhibitors of the human microsomal epoxide hydrolase.
AID664448Inhibition of Wistar/ST rat lung NAAA assessed as conversion of [14C]PEA to [14C]palmitic acid at 100 uM after 20 mins2012Bioorganic & medicinal chemistry, Jun-01, Volume: 20, Issue:11
Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase.
AID1134929Induction of cell lysis in ox RBC at 0.188 mM measured at 4 hrs (Rvb = 1.8 %)1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Lysosomotropic agents. 1. Synthesis and cytotoxic action of lysosomotropic detergents.
AID1134930Induction of cell lysis in ox RBC at 0.188 mM measured at 1 hr (Rvb = 1.7 %)1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Lysosomotropic agents. 1. Synthesis and cytotoxic action of lysosomotropic detergents.
AID1134914Dissociation constant, pKa of the compound1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Lysosomotropic agents. 1. Synthesis and cytotoxic action of lysosomotropic detergents.
AID1691497Inhibition of human mEH using CMNGC as substrate preincubated for 5 mins followed by substrate addition and measured at 30 secs interval for 10 mins by fluorescence assay2020European journal of medicinal chemistry, May-01, Volume: 193Development of potent inhibitors of the human microsomal epoxide hydrolase.
AID1134928Induction of cell lysis in ox RBC at 0.375 mM measured at 4 hrs (Rvb = 1.8 %)1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Lysosomotropic agents. 1. Synthesis and cytotoxic action of lysosomotropic detergents.
AID63727Concentration required against dynamin-1 GTPase activity of sheep brain.2004Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
Long chain amines and long chain ammonium salts as novel inhibitors of dynamin GTPase activity.
AID1134927Induction of cell lysis in ox RBC at 0.375 mM measured at 1 hr (Rvb = 1.7 %)1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Lysosomotropic agents. 1. Synthesis and cytotoxic action of lysosomotropic detergents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (135)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (10.37)18.7374
1990's12 (8.89)18.2507
2000's47 (34.81)29.6817
2010's54 (40.00)24.3611
2020's8 (5.93)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.86 (24.57)
Research Supply Index4.96 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index65.78 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (0.70%)4.05%
Observational0 (0.00%)0.25%
Other141 (99.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]